Trials / Conditions / CNS Malignancies
CNS Malignancies
4 registered clinical trials studyying CNS Malignancies — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressiv NCT07017816 | Children's National Research Institute | EARLY_Phase 1 |
| Withdrawn | Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine NCT06466798 | Jeffrey Treiber | Phase 1 |
| Completed | A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors NCT02564198 | Eli Lilly and Company | Phase 1 |
| Completed | A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors NCT00756340 | St. Jude Children's Research Hospital | Phase 1 |